Markers in Infants of Mothers With Asthma and Associations With Respiratory Outcomes

Carla Rebeca Da Silva Sena1,2,3,4, Gabriela Martins Costa Gomes2,3, Noëmi Künstle1,4

  • 1University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.

Allergy
|September 15, 2025
PubMed

Insights

Cord blood protein levels differ in infants born to asthmatic mothers, impacting lung development. These protein differences are linked to infant lung function, hospitalization risk, and childhood asthma.

Area of Science:

  • Perinatal programming
  • Respiratory medicine
  • Immunology

Background:

  • Maternal asthma may affect fetal lung development via oxidative stress, inflammation, and extracellular matrix turnover.
  • Cord blood protein profiles may serve as biomarkers for offspring respiratory health.
  • Investigating these proteins can elucidate mechanisms linking maternal asthma to infant respiratory outcomes.

Purpose of the Study:

  • To compare cord blood protein levels between infants of asthmatic and non-asthmatic mothers.
  • To examine associations between these protein levels and infant lung function.
  • To assess links to bronchiolitis hospitalization and childhood asthma development.

Main Methods:

  • Utilized data from 715 infants across two birth cohorts (Basel-Bern Infant Lung Development and Breathing for Life Trial).
  • Employed Tobit regression and network analyses for protein level comparisons.
  • Applied adjusted linear and logistic regression to analyze associations with postnatal outcomes.

Main Results:

  • Infants of asthmatic mothers showed lower matrix metalloproteinase-9 (MMP-9) and Interferon gamma (IFN-γ) levels, and higher p62 levels.
  • p62 levels correlated inversely with minute ventilation; IFN-γ and MMP-9 inversely correlated with functional residual capacity.
  • Lower MMP-9 levels were associated with reduced risk of bronchiolitis hospitalization and childhood asthma.

Conclusions:

  • Distinct cord blood protein profiles are observed in offspring of asthmatic mothers.
  • These proteins serve as potential biomarkers linking maternal asthma to infant respiratory health.
  • Findings highlight specific proteins (MMP-9, IFN-γ, p62) as crucial in early-life respiratory development and disease risk.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.3K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
978
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.7K